Sarah Bernard, our Senior Director of BD North America, will be attending the AI-Driven Drug Discovery Summit 2024! With AI revolutionizing the drug discovery landscape, Sarah will be diving deep into discussions on how cutting-edge tech can accelerate innovation, streamline drug development, and improve patient outcomes. From AI-driven target identification to real-world data utilization, this event promises to spark powerful insights and collaborations. Connect with Sarah to arrange a meeting with her! #AIDrugDiscovery #PharmaInnovation #DrugDiscovey
Axxam
Ricerca biotecnologica
Bresso (Milan), MI 10.803 follower
Translating innovative biology into bioactive molecules
Chi siamo
Axxam is a leading provider of integrated discovery services across the life sciences industry with headquarters in Milan, Italy. Within the drug discovery disciplines, we support pharma, biotech companies, start-ups, patient foundations as well as academic groups in their journey from hit identification to lead generation, regardless of the therapeutic area and target class. Our services include assay development, high-throughput screening, using either Axxam's high quality compound collections (synthetic and natural) or those provided by clients, hit validation and compound management. The same science-driven approach is also applied to identify new bioactive compounds for crop protection, animal health, food, beverage, pet food, cosmetic and perfume industries.
- Sito Web
-
https://axxam.com/
Link esterno per Axxam
- Settore
- Ricerca biotecnologica
- Dimensioni dell’azienda
- 51-200 dipendenti
- Sede principale
- Bresso (Milan), MI
- Tipo
- Società privata non quotata
- Data di fondazione
- 2001
- Settori di competenza
- Molecular Biology, High Throughput Screening (HTS), High Content Screening (HCS), Hit Characterization and Profiling, Cardiac Safety and Liability Profiling, Electrophysiology, Assay Development and Optimization, Small Molecule Library for Hit Identification, Phenotypic Assays, Biochemical Assays, Cell-based Assays e iPSC-derived Cell-based Assays
Località
Dipendenti presso Axxam
-
Marco Di Santo
IT Manager at Axxam S.p.A
-
Samuel Bradberry
(Data) Scientist | Scientific Software Development and Implementation | Biotech, Chemical and Life Science
-
Flavia Mazzarol
Business Development Manager for early drug discovery services: hit discovery programs including cell-based assays, biochemical assay development…
-
Alessandro Sidoli
Chief Executive Officer at Axxam SpA
Aggiornamenti
-
🌱 Unlock Nature's potential with the NatPure Library 🌱 Explore the world’s largest pure natural product collection, NatPure – a treasure trove of over 15.000 compounds from plant and microbial sources designed for innovative screening solutions! With 30% novel, unpublished compounds and 4,900 unique chemical clusters, NatPure is redefining chemical diversity. ✨ Fully characterized with solids available for every compound. NatPure offers the unparalleled proprietary collection you need to drive discovery forward. Ready to screen nature’s best? #NatPure #CompoundLibrary #DrugDiscovery
-
🔒 Quality and data safety are essential in drug discovery. Axxam proudly holds ISO 9001 and ISO 27001 certifications, showcasing our commitment to continuous quality improvement and robust data protection. With stringent independent audits and advanced data security measures, we ensure reliable, secure processes for our clients. Discover more about our dedication to quality and information safety: https://lnkd.in/dE-JzczA #ISO #Security #Quality #DrugDiscovery
-
We’re excited to announce the launch of our new LinkedIn Science Spyglass Newsletter – your go-to source for insights into the latest in drug discovery, cutting-edge biological sciences, and innovations shaping the future of biotech. Our first article is about thermal-shift assay (TSA), a powerful tool to study protein stability and interactions in early drug discovery. 💫 Follow along to stay informed, inspired, and connected to the science that’s driving our work at Axxam. #ScienceSpyglass #Newsletter #DrugDiscovery
-
Tom Grammatopoulos, PhD, our BD Senior Director BD North America, will be attending the Hit ID Summit 2024 in Boston! The Hit ID Summit 2024 is a prominent event focused on drug discovery, with an emphasis on hit identification (Hit ID) strategies and medicinal chemistry. Be sure to connect with him for insights into our contributions to advancing drug discovery. 📅 Date: October 12-14, 2024 📍 Location: Boston, MA, USA #HitIDSummit #DrugDiscovery #Conference
-
In the upcoming webinar, we will provide selected cases for ectopic olfactory or taste receptors as potential drug targets together with AXXSense’s receptor platform for ligand discovery and characterization. Watch the video to discover Stefan’s reflections on this webinar! 📅 Tuesday, 12 November 2024 at 16.00 CET / 10.00 ET / 07.00 PT ❇️Ectopic Taste and Olfactory Receptors – Ubiquitous Chemosensation If you want to register click here: https://lnkd.in/d_Bhipqx #OlfactoryReceptor #TasteReceptor #DrugDiscovery #Webinar
-
Day 1 at BIO-Europe: Complete! ✅ We're just getting started! Two more days to connect with our BD team—Sabrina Corazza, Katherina Orellana and Kerstin-Maike Schmitz—who are ready to discuss how Axxam can support your drug discovery journey. Share your challenges and let's explore solutions together! #BIOEurope #DrugDiscovery #TeamAxxam #LifeSciences
-
Axxam is proud to show our commitment to Men’s Health this "MOVEMBER" By updating our logo for November, we’re hoping to help spark conversations about critical issues like prostate cancer, mental health and overall wellness for men. At Axxam, we believe in driving positive change — not only through our work in drug discovery but also in standing together for causes that affect us all. Join us this month in supporting the fight against men’s health challenges. Every small action counts. #Movember #MensHealth #Axxam
-
Join us for a live Boot Camp webinar on World Quality Day: 📅 Thursday 14 November 2024 at 16.00 CET / 10.00 ET / 07.00 PT ❇️ Quality as a success factor in drug discovery This webinar will focus on how implementing quality management systems and ISO certifications contributes to the success of early drug discovery projects. Please use the external event link given to register and subsequently receive your link to join the session -----> https://lnkd.in/dZu36CdG #quality #WorldQualityWeek #ISOcertification #drugdiscovery #webinar
Questo contenuto non è disponibile qui
Accedi a questo contenuto e molto altro nell’app LinkedIn
-
Axxam ha diffuso questo post
4 years ago Manuel found this while performing manual lysopatch !! Quite spooky isn't it? 👻 🧟♂️ Well, the amazing thing is that today, in Axxam, we can patch 384 lysosomes in one experiment, perform cumulative IC/EC50 experiments and even exchange intraluminal solutions on the fly !!! 💫 🎉 #scienceisfun #automatedpatchclamp #drugdiscovery #innovation
Pagine affiliate
Pagine simili
Sfoglia le offerte di lavoro
Raccolta fondi
Ultimo round
Grant340.000,00 USD